Parameter Heterogeneity In Breast Cancer Cost Regressions - Evidence From Five European Countries
Open Access
- 3 December 2015
- journal article
- research article
- Published by Wiley in Health Economics
- Vol. 24 (S2) , 23-37
Abstract
We investigate parameter heterogeneity in breast cancer 1‐year cumulative hospital costs across five European countries as part of the EuroHOPE project. The paper aims to explore whether conditional mean effects provide a suitable representation of the national variation in hospital costs. A cohort of patients with a primary diagnosis of invasive breast cancer (ICD‐9 codes 174 and ICD‐10 C50 codes) is derived using routinely collected individual breast cancer data from Finland, the metropolitan area of Turin (Italy), Norway, Scotland and Sweden. Conditional mean effects are estimated by ordinary least squares for each country, and quantile regressions are used to explore heterogeneity across the conditional quantile distribution. Point estimates based on conditional mean effects provide a good approximation of treatment response for some key demographic and diagnostic specific variables (e.g. age and ICD‐10 diagnosis) across the conditional quantile distribution. For many policy variables of interest, however, there is considerable evidence of parameter heterogeneity that is concealed if decisions are based solely on conditional mean results. The use of quantile regression methods reinforce the need to consider beyond an average effect given the greater recognition that breast cancer is a complex disease reflecting patient heterogeneity. © 2015 The Authors. Health Economics Published by John Wiley & Sons Ltd.Keywords
This publication has 23 references indexed in Scilit:
- Comparability of stage data in cancer registries in six countries: Lessons from the International Cancer Benchmarking PartnershipInternational Journal of Cancer, 2012
- Heterogeneity in breast cancerJournal of Clinical Investigation, 2011
- SPOILT FOR CHOICE: IMPLICATIONS OF USING ALTERNATIVE METHODS OF COSTING HOSPITAL EPISODE STATISTICSHealth Economics, 2011
- The Identification of “Unusual” Health-Care Providers From a Hierarchical ModelThe American Statistician, 2011
- Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry dataBMJ, 2011
- Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populationsAnnals of Oncology, 2008
- Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 studyThe Lancet Oncology, 2007
- Parametric modelling of cost data in medical studiesStatistics in Medicine, 2004
- Quantile RegressionJournal of Economic Perspectives, 2001
- Instrumental Variables Regression with Weak InstrumentsEconometrica, 1997